Antibiotic Adjuvants
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
46
NCT06360640
A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 2, 2024
Completion: Mar 10, 2025
Loading map...